56Indexed trials
Market Rank #35 · Evidence Tier A
Romania
Neuroscience Intelligence
Romania neuroscience intelligence: 56 indexed trials, 6 institutions, research score 26.64.
9Recruiting
6Research institutions
26.6Research score
Evidence profile
37Sponsors
14Disease areas
0Institution works
0Institution citations
Model signals
Opportunity 27 · ML priority 27 · Confidence 100 · Evidence 26.6
These are comparative evidence signals. They do not represent a guarantee of market size or commercial outcome.
Leading disease areas
epilepsy11trials
parkinsons10trials
alzheimers6trials
multiple_sclerosis5trials
stroke3trials
schizophrenia3trials
other_neurology2trials
depression2trials
neuromuscular1trials
migraine_headache1trials
Leading indexed sponsors
Eli Lilly and Company4trials
AbbVie3trials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3trials
Hoffmann-La Roche3trials
Merck Sharp & Dohme LLC3trials
Novo Nordisk A/S3trials
Novartis Pharmaceuticals2trials
Celgene2trials
Boehringer Ingelheim2trials
Eisai Limited2trials